Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets:
Cash	$ 1,485	$ 1,120
Prepaid expenses	97,132	1,975
Total current assets	98,617	3,095
Total assets	98,617	3,095
Current liabilities:
Bank overdrafts		13,749
Accounts payable and accrued expenses	4,948,890	5,455,063
Accrued payroll and related expenses	3,864,055	3,724,050
Advances	88,187	337,500
Non-convertible notes payable, current portion	159,520	115,750
Derivative liabilities	25,475,514	20,236,870
Convertible notes payable, net of debt discount of $0 and $380,431, respectively	3,186,303	6,989,039
Total current liabilities	37,722,469	36,872,021
Non-convertible notes payable	60,000
PPP note payable	50,000
Total liabilities	37,832,469	36,872,021
Commitments and contingencies (See Note 8)
Stockholders’ deficit:
Preferred stock value
Common stock, $0.001 par value, 500,000,000 shares authorized; 493,726,405 and 384,266,948 shares issued and outstanding, respectively	493,727	384,267
Common stock to be issued, 907,379,814 and 944,659,814 shares, respectively	907,380	944,660
Additional paid in capital	283,024,527	151,364,371
Discount on preferred stock	(20,973,776)
Accumulated deficit	(301,185,712)	(189,562,225)
Total stockholders’ deficit	(37,733,852)	(36,868,926)
Total liabilities and stockholders’ deficit	98,617	3,095
Series X Preferred Stock
Stockholders’ deficit:
Preferred stock value
Series Y Preferred Stock
Stockholders’ deficit:
Preferred stock value	1
Total stockholders’ deficit	1
Series C Preferred Stock
Stockholders’ deficit:
Preferred stock value	1	1
Total stockholders’ deficit	1	1
Series A Preferred Stock
Stockholders’ deficit:
Preferred stock value
Series B Preferred Stock
Stockholders’ deficit:
Preferred stock value